GlassScriptPhysician profile
Deepali Kashyap
NPI 1821236084
$2,021.85
in general payments reported to CMS, 2019-2025
27 companies · $212 in 2025
The $212 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $52.68 · 2020: $87.77 · 2021: $226 · 2022: $234 · 2023: $619 · 2024: $590 · 2025: $212.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,336 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,336.26 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $195.46 | 2021-2024 | |
| Astellas Pharma US INC | $192.54 | 2023-2025 | Veozah |
| Sumitomo Pharma America, INC. | $182.64 | 2023-2025 | Myfembree |
| Janssen Biotech, INC. | $149.95 | 2023 | Stelara |
| Galderma Laboratories, L.P. | $142.32 | 2024 | |
| Intra-Sana Laboratories | $140.68 | 2024 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Abbott Laboratories | $140.01 | 2024 | Freestyle Libre 3 |
| Pfizer INC. | $126.75 | 2021-2025 | |
| Biohaven Pharmaceuticals, INC. | $99.77 | 2021 | |
| Mayne Pharma Commercial LLC | $85.51 | 2023-2025 | |
| Organon LLC | $64.32 | 2022-2024 | Nexplanon |
| Minerva Surgical, INC | $61.75 | 2020-2022 | |
| Therapeuticsmd, INC. | $60.61 | 2021-2022 | |
| Myovant Sciences INC. | $49.67 | 2021-2022 | |
| Lupin INC. | $47.45 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Agile Therapeutics, INC. | $47.01 | 2021-2023 | Twirla |
| Bayer Healthcare Pharmaceuticals INC. | $42.34 | 2022-2025 | |
| Hologic Sales and Service, LLC | $29.83 | 2020-2024 | Thinprep 2000 Processor |
| Cosette Pharmaceuticals INC. | $22.01 | 2024 | Vyleesi |
| Evofem Biosciences, INC. | $21.54 | 2022 | |
| Covidien LP | $20.32 | 2019 | |
| Millicent US INC | $19.44 | 2025 | Femlyv |
| Daiichi Sankyo INC. | $17.40 | 2019 | |
| C. R. Bard, INC. & Subsidiaries | $17.07 | 2023 | Bd Onclarity |
| Mylan Pharmaceuticals INC. | $15.39 | 2021 | |
| Ethicon US, LLC | $15.11 | 2022 | |
| Allergan, INC. | $14.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Deepali Kashyap listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.